👉👉 🇺🇸 All Posts 🇬🇧 / 🇯🇵 記事一覧 🇯🇵 👈👈
♦️ Introduction
A 68-year-old patient suddenly develops symptomatic bradycardia (HR 38 bpm) during spinal anesthesia. Your first instinct might be to reach for atropine. But pause for a moment—is this the right kind of bradycardia for atropine?
✅ Answer: In this case, atropine IS effective.
Bradycardia during spinal anesthesia results from sympathetic blockade and relative vagal predominance. Since this is a vagally mediated bradycardia, atropine 0.5-1 mg IV is the first-line treatment.
But— not all bradycardias are this straightforward.
Using atropine in the wrong situation can make no difference at all—or worse, actually cause harm. Particularly if your patient has a history of high-degree AV block, concurrent myocardial infarction, or a history of acute angle-closure glaucoma, you need to reconsider atropine use.
Let’s walk through the key situations where atropine doesn’t work or should be avoided entirely.
❓ Why Atropine Fails in Some Bradycardias
Atropine is an antimuscarinic agent—it blocks acetylcholine at parasympathetic receptors. Within the cardiac conduction system, this means it reduces vagal tone at the sinoatrial (SA) and atrioventricular (AV) nodes. When vagal inhibition decreases, sympathetic influence becomes dominant, and the heart rate rises.
💡 Key Point: Atropine’s effect is limited to the SA and AV nodes. If bradycardia comes from a problem below the AV node (an infranodal block), atropine can’t reach the problem—it doesn’t fix conduction failure in the His-Purkinje system. In these cases, giving atropine won’t help and may delay effective treatment.
🤔 When Atropine Can Harm: Key Contraindications
Atropine can be life-saving in the right scenario—but dangerous in the wrong one. Before you give it, make sure none of these contraindications are present.
👀 Acute Angle-Closure Glaucoma
This is a critical contraindication. Atropine dilates the pupils by blocking muscarinic receptors in the eye. That dilation can obstruct aqueous humor outflow and sharply raise intraocular pressure, triggering acute angle-closure glaucoma, a vision-threatening emergency.
🫀 Coronary Artery Disease (CAD)
⚠️ Use extreme caution in patients with acute myocardial infarction (MI) or severe CAD. Even a standard 1 mg dose of atropine can raise heart rate by 30–40 bpm, sharply increasing myocardial oxygen demand. This can worsen ischemia, enlarge the infarct, or provoke dangerous ventricular arrhythmias. In these settings, other interventions—like pacing—are often safer.
🚰 Obstructive Uropathy
In patients with prostatic hypertrophy or bladder outlet obstruction, atropine’s anticholinergic effects can suppress detrusor muscle function, causing acute urinary retention. Always consider this risk before use in older male patients.
🙅 Which Arrhythmias Don’t Respond to Atropine?
Some bradyarrhythmias simply won’t respond to atropine, no matter the dose. In these cases, it’s better to move directly to alternative therapies.
🔹 High-Degree AV Blocks
Atropine is ineffective for Mobitz Type II and third-degree (complete) heart block. These are infranodal blocks, meaning the conduction failure occurs below the AV node, where atropine has no effect.
💡 Important Distinction:
- Mobitz Type I (Wenckebach): Usually occurs at the AV node and often improves with atropine—especially if it’s due to increased vagal tone (for example, during sleep, after vagal maneuvers, or in well-trained athletes).
 - Mobitz Type II: Occurs below the AV node and will not respond to atropine. Recognizing this difference is key during emergencies.
 
🔹 Heart Transplant Patients
In heart transplant recipients, the heart is denervated—there’s no vagal innervation left. Without parasympathetic tone, atropine has no substrate to act on. As a result, it’s completely ineffective and should be avoided in these patients.
🔹 Beta-Blocker Overdose
Atropine is not the first-line agent for bradycardia caused by beta-blocker toxicity. These patients require high-dose intravenous glucagon, which directly stimulates the heart via cAMP pathways, bypassing the blocked beta receptors.
✅ What to Do Instead: Alternative Management
When atropine doesn’t work—or when it’s contraindicated—you need to act quickly. Here’s what to do next:
🔹 Transcutaneous Pacing (TCP)
If your patient is hemodynamically unstable and doesn’t respond to atropine, move immediately to TCP. This is the preferred next step for unstable bradycardia or any high-degree AV block where atropine is predictably ineffective.
🔹 Catecholamine Infusion
Infusions of epinephrine or dopamine can provide temporary chronotropic support and stabilize blood pressure.
- Epinephrine is generally preferred for isolated bradycardia.
 - Dopamine is a better choice when hypotension is also present.
 
🔹 Glucagon
📌 Keep this in mind as the specific antidote for suspected beta-blocker or calcium channel blocker overdose. It’s the right tool for that job—not atropine.
📖 Frequently Asked Questions🤔
Q: Can atropine worsen glaucoma?
A: Yes. Atropine dilates the pupil (mydriasis), which can block aqueous humor drainage in patients with narrow anterior chamber angles. This may trigger acute angle-closure glaucoma, causing severe eye pain and sudden vision loss. It’s a true emergency.
Q: Why doesn’t atropine work in complete heart block?
A: Complete (third-degree) AV block means conduction has failed below the AV node, in the His-Purkinje system. Since atropine only enhances conduction through the AV node, it can’t overcome a block that’s farther down. Immediate pacing is the definitive treatment.
Q: Is atropine safe in acute myocardial infarction?
A: Use it only with extreme caution. The tachycardia it induces increases myocardial oxygen demand, which can enlarge the infarct or cause ventricular arrhythmias. For bradycardia in the setting of acute MI, transcutaneous pacing is often a safer choice.
Q: Does all glaucoma mean atropine is contraindicated?
A: No—only acute angle-closure glaucoma is an absolute contraindication. Open-angle glaucoma, the most common type, is generally not a contraindication to atropine use, though ophthalmology consultation is recommended when possible.
Additionally, patients who have undergone cataract surgery typically have wider anterior chamber angles, which significantly reduces the risk of angle-closure. In post-cataract patients, atropine can usually be used safely without major concern for precipitating acute glaucoma.
💡 Clinical Pearl: If you’re uncertain about a patient’s glaucoma type or anterior chamber anatomy, a brief ophthalmology consultation—or review of their surgical history—can clarify the risk and guide safe medication use.
📝 Take Home Messages
Atropine is effective only for vagally mediated bradycardias—like sinus bradycardia or Mobitz I AV block. It’s ineffective or dangerous in high-degree AV blocks, acute angle-closure glaucoma, and post-heart transplant patients.
🔑 Key Points
- ✅ DO use atropine for symptomatic sinus bradycardia and Mobitz Type I AV block due to high vagal tone.
 - ❌ DON’T use it for Mobitz Type II or third-degree heart block—the lesion is infranodal and won’t respond.
 - 🔴 CONTRAINDICATED in acute angle-closure glaucoma.
 - ⚠️ INEFFECTIVE in heart transplant patients (no vagal innervation).
 - 🔄 PIVOT quickly to transcutaneous pacing or catecholamine infusions (epinephrine, dopamine) if atropine fails or is contraindicated.
 - 📌 For beta-blocker overdose, the correct antidote is glucagon, not atropine.
 
📚 References & Further reading
- McLendon K, Preuss CV. Atropine. StatPearls. 2023 Jul 5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470551/ [Open Access]
 - JRC Cardiac Arrhythmia Task Force. Initial Dose of Intravenous Atropine for Patients With Symptomatic Bradycardia. Circ Rep. 2025 Sep 26. Available from: https://www.jstage.jst.go.jp/article/circrep/advpub/0/advpub_CR-25-0169/_html/-char/ja [Open Access]
 - WikiAnesthesia Editors. Atropine. WikiAnesthesia. 2024 Jan 9. Available from: https://wikianesthesia.org/wiki/Atropine [Open Access]
 
🔗 Related articles
- to be added
 
